Compliance with growth hormone therapy in chronic renal failure and post transplant.
An anonymous questionnaire to investigate non-compliance with recombinant human growth hormone (rhGH), its causes and correlation with growth response, was sent to 60 children with renal disease; 48% returned the questionnaires; 69% reported that they were concerned about their size and 83% reported being treated as younger than they were. Understanding of the purpose and administration of rhGH was good; 62% missed some rhGH injections, but there was no correlation with understanding or difficulty with the injections, concern regarding size or growth response.